BioVie (BIVI) Short Interest Ratio & Short Volume $0.82 -0.01 (-1.26%) As of 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BioVie Short Interest DataBioVie (BIVI) has a short interest of 1.14 million shares, representing 6.44% of the float (the number of shares available for trading by the public). This marks a -19.15% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.3, indicating that it would take 3.3 days of the average trading volume of 1.76 million shares to cover all short positions.Current Short Interest1,140,000 sharesPrevious Short Interest1,410,000 sharesChange Vs. Previous Month-19.15%Dollar Volume Sold Short$936,054.00Short Interest Ratio3.3 Days to CoverLast Record DateApril 15, 2025Outstanding Shares18,452,000 sharesShort Percent of Float6.44%Today's Trading Volume80,010 sharesAverage Trading Volume1,761,640 sharesToday's Volume Vs. Average5% Short Selling BioVie? Sign up to receive the latest short interest report for BioVie and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBIVI Short Interest Over TimeBIVI Days to Cover Over TimeBIVI Percentage of Float Shorted Over Time BioVie Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20251,140,000 shares $936,054.00 -19.2%6.4%3.3 $0.82 3/31/20251,410,000 shares $1.38 million +12.8%8.0%2.6 $0.98 3/15/20251,250,000 shares $1.35 million -23.8%7.1%1.9 $1.08 2/28/20251,640,000 shares $2.18 million -8.4%9.3%1.9 $1.33 2/15/20251,790,000 shares $3.28 million +21.8%10.1%1.7 $1.83 1/31/20251,470,000 shares $2.43 million -13.5%N/A1 $1.65 1/15/20251,700,000 shares $3.77 million +45.3%N/A0.5 $2.22 12/31/20241,170,000 shares $2.34 million -44.0%N/A0.2 $2.00 12/15/20242,090,000 shares $5.52 million +13.6%N/A0.3 $2.64 11/30/20241,840,000 shares $5.15 million +36.3%N/A0.3 $2.80 Get the Latest News and Ratings for BIVI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioVie and its competitors with MarketBeat's FREE daily newsletter. 11/15/20241,350,000 shares $4.31 million -29.7%19.6%0.2 $3.19 10/31/20241,920,000 shares $5.26 million +922.9%35.0%0.4 $2.74 10/15/2024187,700 shares $206,470.00 -51.0%3.4%0 $1.10 9/30/2024383,100 shares $459,720.00 +174.0%7.0%2.2 $1.20 9/15/2024139,800 shares $441,768.00 -8.3%3.7%0.9 $3.16 8/31/2024152,400 shares $423,672.00 +52.4%4.1%1.5 $2.78 8/15/2024100,000 shares $237,000.00 +14.7%2.7%1 $2.37 7/31/202487,200 shares $33,955.68 -61.6%1.4%1.2 $0.39 7/15/2024226,900 shares $98,928.40 -83.8%N/A0.4 $0.44 6/30/20241,400,000 shares $560,700.00 +23.9%N/A2.5 $0.40 6/15/20241,130,000 shares $519,913.00 -5.8%N/A1.8 $0.46 5/31/20241,200,000 shares $546,600.00 +10.1%N/A1.5 $0.46 5/15/20241,090,000 shares $539,441.00 -14.2%N/A0.4 $0.49 4/30/20241,270,000 shares $622,300.00 +14.4%N/A0.5 $0.49 4/15/20241,110,000 shares $546,897.00 -25.0%N/A0.4 $0.49 3/31/20241,480,000 shares $782,328.00 -3.9%N/A0.6 $0.53 3/15/20241,540,000 shares $1.09 million +51.0%N/A0.7 $0.71 2/29/20241,020,000 shares $1.26 million -1.0%N/A0.5 $1.24 2/15/20241,030,000 shares $1.22 million -5.5%N/A1.8 $1.18 1/31/20241,090,000 shares $1.13 million -36.3%N/A1.6 $1.04 1/15/20241,710,000 shares $2.14 million -3.4%N/A2.1 $1.25 12/31/20231,770,000 shares $2.23 million +19.6%N/A2.3 $1.26 12/15/20231,480,000 shares $2.15 million -40.6%N/A2 $1.45 11/30/20232,490,000 shares $4.48 million +16.4%18.4%3.6 $1.80 11/15/20232,140,000 shares $6.74 million -19.3%15.6%4.7 $3.15 10/31/20232,650,000 shares $11.55 million +25.0%19.9%7.8 $4.36 10/15/20232,120,000 shares $7.48 million +1.4%15.9%10.5 $3.53 9/30/20232,090,000 shares $7.13 million +5.6%15.7%9.9 $3.41 9/15/20231,980,000 shares $6.53 million +30.3%14.9%8.3 $3.30 8/31/20231,520,000 shares $4.73 million +22.6%11.8%6.2 $3.11Top performing AI play of the decade…? (The answer will shock you) (Ad)You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is about to announce could change the AI market once again. Experts already predict the total addressable market could climb past $20 trillion. But Sykes believes most investors have missed what’s coming next. He’s tracking a new shift — and says the biggest gains are still ahead.Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. 8/15/20231,240,000 shares $4.91 million +0.8%10.0%5 $3.96 7/31/20231,230,000 shares $5.81 million +23.1%10.1%5.1 $4.72 7/15/2023998,900 shares $5.04 million -10.0%8.2%4.3 $5.05 6/30/20231,110,000 shares $4.78 million +81.6%9.1%4.9 $4.31 6/15/2023611,400 shares $3.53 million +6.4%4.9%2.5 $5.78 5/31/2023574,400 shares $3.35 million +36.0%4.7%2.2 $5.84 5/15/2023422,400 shares $3.15 million -21.4%3.5%1.2 $7.46 4/30/2023537,400 shares $4.29 million -0.1%4.7%1.5 $7.99 4/15/2023538,100 shares $4.28 million -6.8%4.7%1.4 $7.95 3/31/2023577,500 shares $4.67 million +18.8%5.2%1.4 $8.08 3/15/2023486,000 shares $4.78 million +34.2%4.4%0.8 $9.83 2/28/2023362,100 shares $2.78 million -7.1%3.3%0.3 $7.69 2/15/2023389,800 shares $2.17 million +21.3%5.2%0.4 $5.57 1/31/2023321,300 shares $1.63 million -18.0%4.9%0.3 $5.07 1/15/2023391,600 shares $2.15 million -14.6%5.9%0.3 $5.50 12/30/2022458,500 shares $3.56 million -25.2%6.5%0.4 $7.77 12/15/2022612,700 shares $7.81 million +61.5%8.7%0.6 $12.74 11/30/2022379,400 shares $2.56 million +68.0%5.4%0.6 $6.74 11/15/2022225,900 shares $1.12 million +34.5%3.2%0.5 $4.97 10/31/2022167,900 shares $710,217.00 +35.5%9.8%0.4 $4.23 10/15/2022123,900 shares $324,618.00 -11.1%7.3%0.3 $2.62 9/30/2022139,300 shares $346,857.00 -29.2%8.2%0.4 $2.49 9/15/2022196,800 shares $495,936.00 +198.6%14.1%0.6 $2.52 8/31/202265,900 shares $237,899.00 +20.7%4.5%0.2 $3.61 8/15/202254,600 shares $129,948.00 -21.4%3.7%1 $2.38 7/31/202269,500 shares $149,425.00 -11.2%1.4%1.3 $2.15 7/15/202278,300 shares $140,157.00 +19.2%1.5%1.6 $1.79 6/30/202265,700 shares $95,265.00 -10.0%1.3%1.4 $1.45 6/15/202273,000 shares $124,830.00 -6.7%1.4%1.4 $1.71 5/31/202278,200 shares $200,192.00 -35.7%1.5%1.9 $2.56 5/15/2022121,700 shares $318,854.00 -14.7%2.4%3.2 $2.62 4/30/2022142,700 shares $530,844.00 -2.5%2.8%3.2 $3.72 4/15/2022146,400 shares $647,088.00 +9.8%2.9%2.7 $4.42 3/31/2022133,400 shares $629,648.00 -20.9%2.6%2.5 $4.72 3/15/2022168,700 shares $474,047.00 +10.3%3.3%3.6 $2.81 2/28/2022152,900 shares $475,519.00 -4.0%3.0%3.3 $3.11 2/15/2022159,300 shares $505,777.50 -11.0%3.1%3 $3.18 1/31/2022178,900 shares $567,113.00 -5.0%3.5%3.2 $3.17 1/15/2022188,400 shares $842,148.00 -21.9%3.7%2.1 $4.47 12/31/2021241,100 shares $1.08 million -5.9%4.8%2.6 $4.50 12/15/2021256,100 shares $1.30 million +12.3%5.1%2.6 $5.07 11/30/2021228,000 shares $1.47 million -14.8%4.6%2.2 $6.44 11/15/2021267,600 shares $1.58 million +13.6%5.4%2.6 $5.89 10/29/2021235,600 shares $1.44 million -12.3%4.8%2.1 $6.12 10/15/2021268,500 shares $1.58 million -12.6%5.5%2.6 $5.90 9/30/2021307,300 shares $2.06 million +7.2%6.2%4.3 $6.69 9/15/2021286,600 shares $2.22 million +5.5%5.8%4.6 $7.76 8/31/2021271,600 shares $2.17 million +15.0%2.2%4.5 $7.98 8/13/2021236,200 shares $1.92 million +9.0%2.0%4.5 $8.13 7/30/2021216,800 shares $3.07 million -10.2%2.0%4.1 $14.14Top performing AI play of the decade…? (The answer will shock you) (Ad)You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is about to announce could change the AI market once again. Experts already predict the total addressable market could climb past $20 trillion. But Sykes believes most investors have missed what’s coming next. He’s tracking a new shift — and says the biggest gains are still ahead.Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. 7/15/2021241,300 shares $3.49 million -4.4%2.2%3.9 $14.48 6/30/2021252,300 shares $4.28 million +9.6%6.2%3.4 $16.95 6/15/2021230,300 shares $3.80 million +3.9%5.7%2.9 $16.50 5/28/2021221,700 shares $3.05 million -3.4%8.7%2.9 $13.75 5/14/2021229,600 shares $2.79 million -9.1%9.2%2.1 $12.15 4/30/2021252,500 shares $4.09 million +31.7%10.2%2.3 $16.21 4/15/2021191,700 shares $2.72 million +16.9%7.8%1.9 $14.20 3/31/2021164,000 shares $2.81 million -7.2%6.7%1.7 $17.13 3/15/2021176,700 shares $3.60 million +62.0%7.2%1.7 $20.40 2/26/2021109,100 shares $3.16 million +37.1%4.4%1 $28.95 2/12/202179,600 shares $2.99 million +32.0%3.2%0.9 $37.51 1/29/202160,300 shares $1.99 million +13.8%2.5%0.8 $33.00 1/15/202153,000 shares $1.59 million No Change2.2%0.8 $29.94 BIVI Short Interest - Frequently Asked Questions What is BioVie's current short interest? Short interest is the volume of BioVie shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 1,140,000 shares of BIVI short. 6.44% of BioVie's shares are currently sold short. Learn More on BioVie's current short interest. What is a good short interest ratio for BioVie? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BIVI shares currently have a short interest ratio of 3.0. Learn More on BioVie's short interest ratio. Which institutional investors are shorting BioVie? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of BioVie: Group One Trading LLC, Concourse Financial Group Securities Inc., and Belvedere Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for BioVie? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.44% of BioVie's floating shares are currently sold short. Is BioVie's short interest increasing or decreasing? BioVie saw a decline in short interest in April. As of April 15th, there was short interest totaling 1,140,000 shares, a decline of 19.1% from the previous total of 1,410,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does BioVie's short interest compare to its competitors? 6.44% of BioVie's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to BioVie: IO Biotech, Inc. (0.23%), PMV Pharmaceuticals, Inc. (1.91%), Assertio Holdings, Inc. (6.05%), Adverum Biotechnologies, Inc. (10.27%), Kronos Bio, Inc. (1.71%), Ikena Oncology, Inc. (0.96%), Precision BioSciences, Inc. (21.96%), BeyondSpring Inc. (6.28%), Milestone Pharmaceuticals Inc. (5.66%), FibroBiologics, Inc. (5.23%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short BioVie stock? Short selling BIVI is an investing strategy that aims to generate trading profit from BioVie as its price is falling. BIVI shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BioVie? A short squeeze for BioVie occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BIVI, which in turn drives the price of the stock up even further. How often is BioVie's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BIVI, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies IOBT Short Interest PMVP Short Interest ASRT Short Interest ADVM Short Interest KRON Short Interest IKNA Short Interest DTIL Short Interest BYSI Short Interest MIST Short Interest FBLG Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BIVI) was last updated on 4/30/2025 by MarketBeat.com Staff From Our Partners"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioVie With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
